Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
Seizure Prophylaxis After Brain Hemorrhage — When to Use, When to Avoid, and Which Agent to Choose
Hossam Qassem/LinkedIn
Nov 26, 2025, 04:54

Seizure Prophylaxis After Brain Hemorrhage — When to Use, When to Avoid, and Which Agent to Choose

Hossam Qassem, ICU Clinical pharmacist at Mabaret AlAsafra Group for Medical Services, shared a post on LinkedIn:

“Day 74

Seizure Prophylaxis After Brain Hemorrhage — When to Use, When to Avoid, and Which Agent to Choose

 

Key Clinical Pearls

1. Spontaneous Brain Hemorrhage — overall stance

Routine AED prophylaxis is not recommended for all spontaneous intracranial hemorrhages.
✔ Use selectively based on:

Cortical involvement

Presence of early seizure

Large clot burden

Need for neurosurgical intervention

Evidence of significant cortical irritation on imaging
Why? No evidence AEDs prevent late seizures; unnecessary use increases neurocognitive adverse effects.

2. Intracerebral Hemorrhage (ICH) — selective prophylaxis only

Do NOT use routinely in spontaneous ICH.
✔ Consider prophylaxis when:

Lobar hematoma

Cortical involvement

Hematoma >30 mL

Intraventricular extension

Early seizure at presentation

Post-operative after hematoma evacuation
Agent of choice: Levetiracetam.

3. Subarachnoid Hemorrhage (SAH)

✔ Aneurysmal SAH = Prophylaxis recommended for 3–7 days, especially when:

High Hunt & Hess grade

Cortical irritation

IVH or hydrocephalus

EVD in place
Avoid long-term use unless seizures occur.
Preferred agent: Levetiracetam (better cognitive profile vs phenytoin).

 

—

4. Traumatic Brain Injury (TBI)

✔ Moderate–severe TBI = 7-day AED prophylaxis
Indications:

GCS ≤ 8

Cortical contusions

Depressed/penetrating skull fractures

Subdural/epidural hematoma
Goal: Prevent early PTS (first 7 days).
AEDs do not prevent late post-traumatic epilepsy.

5. Post-craniotomy / neurosurgical interventions

✔ Prophylaxis recommended in:

Brain tumor resections (especially supratentorial)

Cortical manipulation

Hematoma evacuation

Lobectomy
Usual duration: 7 days, longer if high epileptic potential persists.

 

6. Agent selection, dosing and ICU pearls

Levetiracetam (Keppra) = preferred

500–1,000 mg IV/PO q12h (adjust for renal function)

No CYP interactions

Better neurocognitive profile
Avoid routine phenytoin unless clinically required (drug interactions, toxicity, monitoring burden).
STOP at 7 days if no seizures and no ongoing risk.

7. When to avoid prophylaxis

Low-risk deep ICH (basal ganglia, thalamus)
Uncomplicated cerebellar hemorrhage
SAH with no cortical involvement and no EVD
Mild TBI without cortical injury
Avoid unnecessary therapy to reduce sedation, encephalopathy, and drug interactions.

Guideline Anchors
Neurocritical Care Society (NCS) Seizure Prophylaxis Guidelines
AHA/ASA ICH and SAH Guidelines
Brain Trauma Foundation TBI Guidelines”

Seizure Prophylaxis After Brain Hemorrhage — When to Use, When to Avoid, and Which Agent to Choose

Stay informed with Hemostasis Today.

Health Hematology hemorrhage Hemostasis Hemostasis Today Intracerebral Hemorrhage (ICH) Medicine Neurocritical Care Society (NCS) Seizure Spontaneous Brain Hemorrhage Subarachnoid Hemorrhage (SAH) Traumatic Brain Injury (TBI)
NewsFeed